Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services announced it will resume routine inspections of all Medicare- and Medicaid-certified providers and suppliers that were previously suspended as part of its response to the COVID-19 pandemic.
The Centers for Medicare & Medicaid Services updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.
HHS delayed today’s expected release of additional details regarding data elements for providers who accepted Provider Relief Fund program funds.
FDA Saturday issued an emergency use authorization to Yale School of Public Health for a new test to detect SARS-CoV-2 in saliva.
The CDC recently released guidance for clinicians and laboratory professionals on rapid antigen testing for SARS-CoV-2.
McKesson Corporation will serve as a central distributor of future COVID-19 vaccines and related supplies, the departments of Health and Human Services and Defense announced.
The AHA today issued a Regulatory Advisory summarizing the CMS' inpatient rehabilitation facility prospective payment system final rule for fiscal year 2021.
The Oklahoma Health Care Authority this week withdrew its request for the Centers for Medicare & Medicaid Services to approve a Healthy Adult Opportunity demonstration waiver for its new low-income adult Medicaid population.
Incidence-based mortality for the most common U.S. lung cancer fell about 6% per year between 2013 and 2016 as treatment advances accelerated previous declines, according to a study reported this week in the New England Journal of Medicine.
The U.S. Court of Appeals for the Federal Circuit affirmed a 2019 court order requiring the federal government to reimburse insurers for unpaid cost-sharing reductions provided through the Affordable Care Act’s health insurance exchanges in 2017 and 2018.